This paper deals with the topic of related R&D and innovation strategies of large firms. We ask what determines the diversity of a firm's product portfolio. More specifically, we try to explain large firms' expansion into new product markets driven by the characteristics of their technological...

This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of successful research projects. We provide clear evidence that externally sourced projects and projects involving biotechnologies perform better than internal projects and chemical...

Eine hohe pharmakologische Überlegenheit ist eine wesentliche, jedoch nichtdie einzig bestimmende Voraussetzung für den Erfolg eines innovativenWirkstoffes.• Zur Realisierung der pharmakologisch begründeten Erwartungen in dasMedikament ist der Einsatz eines fortschrittlichen...